Asthma susceptibility due to environmental programming of innate immunity in utero
由于子宫内先天免疫的环境编程而导致哮喘易感性
基本信息
- 批准号:10532221
- 负责人:
- 金额:$ 59.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-01-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAllergic DiseaseAreaAsthmaBiological MarkersBirth WeightBlood specimenBody Weight decreasedCD34 geneCell Differentiation processCellsCessation of lifeChildhood AsthmaCoculture TechniquesCytoplasmic GranulesDataDevelopmentDiesel ExhaustEatingEndowmentEnhancersEnvironmental ExposureEnzyme-Linked Immunosorbent AssayEpithelial CellsEpitheliumExposure toFetal Growth RetardationFetal TissuesFetusFlow CytometryFutureGoalsGranzymeGrowthGrowth InhibitorsHealthHumanImmune responseImmunityImpairmentIn VitroInjectionsInterleukin-13LeadLifeLinkLymphocyteLymphoid CellMaternal ExposureMeasuresMediatingMediatorMetabolicMetabolismMicroscopyModelingMolecularMothersMusNatural ImmunityNatural Killer CellsNull LymphocytesPathway interactionsPeptide HydrolasesPollutionPredispositionPreschool ChildProcessProductionProteinsRiskRoleSTAT6 geneSerumSideSortingStarvationTestingTh2 CellsTimeTissuesToxic Environmental Substancesairway epitheliumcell growthcigarette smokecytokinedesignearly childhoodearly detection biomarkersepidemiology studyfetalfunctional outcomeshematopoietic tissuehigh riskin uteroindexinginstrumentmeetingsmouse modelnoveloffspringparticleprenatalpreventprogenitorprogramspupreceptorreconstitutionrepairedresponsesynergismtherapeutic targettissue repairtraittranscription factortranscriptome sequencingtransmission process
项目摘要
Project Summary/Abstract
A growing number of epidemiological studies link childhood asthma with maternal environmental exposures
with the strongest evidence provided for cigarette smoke and diesel exhaust. Mechanisms how maternal
exposures lead to asthma in offspring are unknown. To address this, we developed a mouse model, inducing
asthma susceptibility in young mice by exposing their mothers to diesel exhaust particles (DEP). We then
discovered that asthma in this model was driven in part by natural killer (NK) cells. This finding was surprising
because it did not fit into the traditional paradigm of NK cells serving as a body’s defense instrument designed
to KILL. Our new data indicate, that instead, NK cells are part of a homeostatic response to REPAIR (NOT kill)
fetal tissues that are metabolically-impaired by diesel exhaust, and that metabolic impairment is the primordial
cause of asthma predisposition in our model. Metabolic impairment of DEP pups manifests itself in their
reduced weight. The body’s first response to growth-limiting insults is induction of pro-survival factors.
Accordingly, hematopoietic tissues of DEP fetuses and pups over-produce growth arrest-specific protein 6
(Gas6), a cytokine known to be induced under conditions of reduced metabolism and impaired growth to
protect tissues from death and promote their repair. Tissue repair has long been linked to type-2 immune
responses. Consistent with this, injections of Gas6 promote type-2 innate lymphoid cell (ILC2) activation and
asthma in normal pups. We hypothesize that Gas6 effects are at least in part due to induction of a type-2
program in developing NK cells, and that this program endows NK cells with a capacity to orchestrate
responses of type-2 lymphocytes. Gas6 is a recognized enhancer of NK cell development. It is also a known
activator of STAT6, a transcriptional factor linked to type-2 differentiation. Accordingly, NK cell development is
enhanced in DEP offspring and their mature NK cells produce the type-2 cytokine IL13. We further show that in
DEP pups, NK cells drive production of epithelial IL25 and activation of ILC2 and Th2 cells. In addition to
producing IL13, DEP NK cells have enhanced ability to degranulate. We propose that these two traits underlie
the unique capacity of DEP NK cells to activate type-2 immunity. We show that the granule protease granzyme
B (Gzmb) potently synergizes with IL13 to induce IL25 from airway epithelial cells. Our overarching hypothesis
is that maternal exposure to DEP promotes asthma susceptibility in offspring by impairing their metabolism and
growth; this provokes a repair response, part of which is induction of Gas6 that programs NK cells for
enhanced secretion of IL13 and granzyme B, leading to production of IL25 and activation of ILC2 and Th2
cells. In Aim 1, we will study NK cell-driven mechanisms of prenatally-programmed asthma, focusing on NK
cell mediators (Gzmb and IL13) and IL25. In Aim 2, we will study importance of Gas6 in NK cell programming
and transmission of asthma susceptibility. In Aim 3, we will use human blood samples to test a hypothesis that
over-activation of the Gas6 pathway in NK cells in early childhood is a predictor of future asthma.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Magdalena Maria Gorska其他文献
Magdalena Maria Gorska的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Magdalena Maria Gorska', 18)}}的其他基金
Maternal programming of the stem cell-basophil axis for asthma
哮喘干细胞-嗜碱性粒细胞轴的母体编程
- 批准号:
10219912 - 财政年份:2020
- 资助金额:
$ 59.81万 - 项目类别:
Maternal programming of the stem cell-basophil axis for asthma
哮喘干细胞-嗜碱性粒细胞轴的母体编程
- 批准号:
9886147 - 财政年份:2020
- 资助金额:
$ 59.81万 - 项目类别:
Maternal programming of the stem cell-basophil axis for asthma
哮喘干细胞-嗜碱性粒细胞轴的母体编程
- 批准号:
10441348 - 财政年份:2020
- 资助金额:
$ 59.81万 - 项目类别:
Asthma susceptibility due to environmental programming of innate immunity in utero
由于子宫内先天免疫的环境编程而导致哮喘易感性
- 批准号:
10318567 - 财政年份:2015
- 资助金额:
$ 59.81万 - 项目类别:
Asthma susceptibility due to environmental programing of innate immunity in utero
由于子宫内先天免疫的环境编程而导致哮喘易感性
- 批准号:
8818875 - 财政年份:2015
- 资助金额:
$ 59.81万 - 项目类别:
Asthma susceptibility due to environmental programing of innate immunity in utero
由于子宫内先天免疫的环境编程而导致哮喘易感性
- 批准号:
8991512 - 财政年份:2015
- 资助金额:
$ 59.81万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 59.81万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 59.81万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 59.81万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 59.81万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 59.81万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 59.81万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 59.81万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 59.81万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 59.81万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 59.81万 - 项目类别: